Increased expression of placenta growth factor in proliferative diabetic retinopathy

Laboratory Investigation

Volumn 78, Issue 1, 1998, Pages 109-116

  Khaliq, Asud ^a   Foreman, David ^b   Ahmed, Asif ^a   Weich, Herbert ^c   Gregor, Zdenek ^d   McLeod, David ^b   Boulton, Mike ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTA PROTEIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; VITRECTOMY;

EID: 0031930349     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Adamis AP, Miller JW, Bernal M-T, D'Amico DJ, Folkman J, Yeo T, and Yeo K (1994). Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450.
2. Adamis AP, Shima DT, Tolentino MJ, Gragoudas E, Ferrara N, Folkman J, D'Amore P, and Miller J (1996). Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularisation in a non-human primate. Arch Ophthalmol 114:66-71.
3. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah S, Pasquale LR, Thieme H, Iwamoto M, and Park JE (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retina disorders. N Engl J Med 331:1480-1487.
4. Ashton N (1957). Retinal vascularisation in health and disease. Am J Ophthalmol 44:7-17.
5. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, and Marme D (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336-3343.
6. Bohling T, Hatva E, Kujala M, Claessonwelsh L, Alitalo K, and Haltia M (1996). Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J Neuropathol Exp Neurol 55:522-527.
7. Boulton M, Gregor Z, McLeod D, Charteris D, Jarvis-Evans J, Moriarty P, Khaliq A, Foreman D, Allamby D, and Bardsley B (1997). Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management. Br J Ophthalmol 81:228-233.
8. Cao Y, Ji WR, Qi P, Rosin A, and Cao Y (1997). Placenta growth factor: Identification and characterisation of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun 235:493-498.
9. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, and Risau W (1996). The vascular endothelial growth factor receptor flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271: 17629-17634.
10. Cunha-Vaz JG, Abreu JF, Campos AJ, and Figo GM (1975). Early breakdown of the blood- retinal barrier in diabetes. Br J Ophthalmol 59:649-656.
11. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, and Claffey KP (1997). Hypoxia upregulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 18:263-268.
12. DiSalvo J, Bayne ML, Conn G, Kwok PW, Prashant GT, Soderman DD, Palisi TM, Sullivan KA, and Thomas KA (1995). Purification and characterization of a naturally ocurring vascular endothelial growth factor, placenta growth factor heterodimer. J Biol Chem 270:7717-7723.
13. Dorey CK, Aouididi S, Raynaud X, Dvorak HF, and Brown LF (1996). Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovasculatisation in the rat. Arch Ophthalmol 114:1210-1217.
14. Dunk C and Ahmed A (1997). Actin fibre formation stimulated by vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) in endothelial cells (abstract). Placenta 8:A20.
15. Ferrara N and Henzel WJ (1989). Pituatory follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858.
16. Ferrara N, Houck K, Jakeman L, and Leung DW (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32.
17. Fong GH, Rossant J, Gertsenstein M, and Breitman ML (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
18. Fredj-Reygrobellet D, Baudouin C, Negre F, Caruelle JP, Gastaud P, and Lapalus P (1991). Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy. Ophthalmic Res 23:154-161.
19. Gleadle JM, Ebert BL, Firth JD, and Ratcliffe PJ (1995a). Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 268:C1362-C1368.
20. Gleadle JM, Ebert BL, and Ratcliffe PJ (1995b). Diphenylene iodonium inhibits induction of erythropoietin and other mammalian genes by hypoxia: Implications for the mechanism of oxygen sensing. Eur J Biochem 234:92-99.
21. Grant M, Russell B, Fitzgerald C, and Merimelt J (1986). Insulin-like growth factors in vitreous: Studies in control and diabetic subjects with neovascularisation. Diabetes 35:416-420.
22. Hata Y, Nakagawa K, Ishibashi T, Inomata H, Ueno H, and Sueishi K (1995). Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Arch 426:479-486.
23. Hatva E, Bohling T, Jaaskelainen J, Persico MG, Haltia M, and Alitalo K (1996). Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 114:66-71.
24. Hauser S and Weich HA (1993). A heparin-binding form of placenta growth factor (PIGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9:259-268.
25. Hercules BL, Gayed II, Lucas SB, and Jeacock J (1977). Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: A three-year interim report of a randomised, controlled study using argon laser. Br J Ophthalmol 61:555-563.
26. Kendall RL, Wang G, DiSalvo J, and Thomas KA (1994). Specificity of vascular endothelial growth factor receptor ligand binding domains. Biochem Biophys Res Comun 201: 326-330.
27. Khaliq A, Jarvis-Evans J, McLeod D, and Boulton ME (1996). Oxygen modulates the response of retinal pigment epithelial cells via receptor regulation. Invest Ophthalmol Vis Sci 37: 436-443.
28. King GL, Goodman AD, Buzney S, Moses A, and Kahn CR (1985). Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capilleries and aorta. J Clin Invest 75:1028-1036.
29. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
30. Lutty GA, McLeod DS, Merges C, Diggs A, and Plouet J (1996). Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 114:971-977.
31. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, and Persico MG (1991). Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271.
32. Maglione D, Guerriero V, Viglietto G, Ferraro M, Aprelikova O, Alitalo K, Del Vecchio S, Lei K, Chou J, and Persico M (1993). Two alternative mRNAs coding for the angiogenic factor, placenta growth factor, (PIGF) are transcribed from a single gene of chromosome 14. Oncogene 8:173-179.
33. Malacaze F, Clemens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, and Plouet J (1994). Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopahty. Arch Ophthalmol 112:1476-1482.
34. Michaelson IC (1948). The mode of development of the vascular system of the retina, with some observation for its significance for certain retinal diseases. Trans Ophthalmol Soc UK 68:137-186.
35. Nomura M, Yamagishi S, Harada S, Hayashi Y, Yamashima T, Yamashita J, and Yamamoto H (1995). Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 270:28316-28324.
36. Park JE, Chen HH, Winer J, Houck KA, and Ferrara N (1994). Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not Flk-1/KDR. J Biol Chem 269:25646-25654.
37. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, and Keshet E (1996). Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 80:241-245.
38. Plouet J, Schilling J, and Gospodarowicz D (1989). Isolation and characterisation of a newly identified endothelial cell mitogen produced by pituatorry AtT-20 cells. EMBO J 8:3801-3806.
39. Sandner P, Wolf K, Bergmaier U, Gess B, and Kurtz A (1997). Induction of VEGF and VEGF gene expression by hypoxia: Divergent regulation in vivo and in vitro. Kidney Int 51:448-453.
40. Sawano A, Takahashi T, Yamaguchi S, Aonuma M, and Shibuya M (1996). Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213-221.
41. Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende R, Folkman J, and D'Amore P (1995a). Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med 1:182-193.
42. Shima DT, Deutsch U, and D'Amore PA (1995b). Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 370:203-208.
43. Simorre-Pinatel V, Guerin M, Chollet P, Penary M, Clamens S, Malecaze F, and Plouet J (1994). Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci 35:3393-3400.
44. Sivalingham A, Kenney J, Brown GC, Benson WE, and Donoso L (1991). Basic fibroblast growth factor levels in the vitreous with proliferative diabetic retinopathy. Arch Ophthalmol 108:869-872.
45. Sueishi K, Hata Y, Murata T, Nakagawa K, Ishibashi T, and Inomata H (1996). Endothelial and glial cell interaction in diabetic retinopathy via the function of vascular endothelial growth factor (VEGF). Pol J Pharmacol 48:307-316.
46. Takagi H, King GL, and Aiello LP (1996a). Identification and characterisation of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 45:1016-1023.
47. Takagi H, King GL, Ferrara N, and Aiello LP (1996b). Hypoxia regulates vascular endothelial growth factor receptor KDR/ Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthamol Vis Sci 37:1311-1321.
48. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, and Terada M (1994). Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233-4237.
49. The Diabetic Retinopathy Study Research Group (1981). Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology 88:583-600.
50. Thieme H, Aiello LP, Takagi H, Ferrara N, and King GL (1995). Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic endothelial cells. Diabetes 44:98-103.
51. Tuber RM, Flook BE, and Voelkel NF (1995). Increaased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt-1 in lungs exposed to acute or chronic hypoxia. J Clin Invest 95:1798-1807.
52. Unemori EN, Ferrara N, Bauer EA, and Amento EP (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153:557-562.
53. Vinores SA, Gadegbeku C, Campochiaro PA, and Green WR (1989). Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol 134:231-235.
54. Weindel K, Moringlane JR, Marme D, and Weich HA (1994). Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor and cyst fluid: The key to angiogenesis? Neurosurgery 35:439-449.
55. Weiter J and Zuckerman R (1980). The influence of the photoreceptor-RPE complex on the inner retina: An explanation for the beneficial effects of photocoagulation. Ophthalmology 87:1133-1139.
56. Wiedemann P (1992). Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 36:373-384.
57. Wise GN (1956). Retinal neovascularisation. Trans Am Ophthalmol Soc 54:729-826.
58. Xiao M, Khaliq A, Moriarty P, McLeod D, Cranley J, and Boulton M (1996). The effect of scatter laser photocoagulation on intravitreal levels of growth factors in the miniature pig. Curr Eye Res 15:923-931.
59. Ziche M, Maglione D, Ribatti D, Morbidelli L, Lago CT, Battisti M, Paoletti I, Barra A, Tucci M, Parise G, Vincenti V, Granger H, Viglietto G, and Persico MG (1997). Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest 76:517-531.